Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

19.28

+0.22 (1.15%)

At close: Apr 25, 2025, 4:00 PM

19.50

+0.22 (1.14%)

Pre-market: Apr 28, 2025, 4:02 AM EDT

Rigel Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Operating Revenue	179.28	115.78	115.74	138.74	108.62	Upgrade
Other Revenue	-	0.1	-	-	-	Upgrade
Revenue	179.28	115.88	115.74	138.74	108.62	Upgrade
Revenue Growth (YoY)	54.71%	0.12%	-16.57%	27.73%	83.21%	Upgrade
Cost of Revenue	42.03	31.63	62.02	66.32	61	Upgrade
Gross Profit	137.25	84.25	53.72	72.42	47.63	Upgrade
Selling, General & Admin	113.06	105.74	112.45	91.89	76.6	Upgrade
Operating Expenses	113.06	105.74	112.45	91.89	76.6	Upgrade
Operating Income	24.19	-21.49	-58.73	-19.48	-28.97	Upgrade
Interest Expense	-7.92	-6.87	-3.71	-4.86	-1.35	Upgrade
Interest & Investment Income	2.09	2.27	0.68	0.05	0.58	Upgrade
EBT Excluding Unusual Items	18.37	-26.09	-61.75	-24.29	-29.74	Upgrade
Merger & Restructuring Charges	-	-	-1.32	-3.52	-	Upgrade
Other Unusual Items	-	1	4.5	10.5	-	Upgrade
Pretax Income	18.37	-25.09	-58.57	-17.31	-29.74	Upgrade
Income Tax Expense	0.88	-	-	0.61	-	Upgrade
Net Income	17.49	-25.09	-58.57	-17.91	-29.74	Upgrade
Net Income to Common	17.49	-25.09	-58.57	-17.91	-29.74	Upgrade
Shares Outstanding (Basic)	18	17	17	17	17	Upgrade
Shares Outstanding (Diluted)	18	17	17	17	17	Upgrade
Shares Change (YoY)	1.64%	2.07%	-0.00%	1.03%	0.81%	Upgrade
EPS (Basic)	0.99	-1.44	-3.44	-1.05	-1.76	Upgrade
EPS (Diluted)	0.99	-1.44	-3.44	-1.05	-1.76	Upgrade
Free Cash Flow	31.44	-5.74	-74.21	5.25	-53.45	Upgrade
Free Cash Flow Per Share	1.78	-0.33	-4.35	0.31	-3.17	Upgrade
Gross Margin	76.56%	72.70%	46.41%	52.20%	43.84%	Upgrade
Operating Margin	13.49%	-18.55%	-50.74%	-14.04%	-26.67%	Upgrade
Profit Margin	9.75%	-21.65%	-50.61%	-12.91%	-27.38%	Upgrade
Free Cash Flow Margin	17.53%	-4.96%	-64.11%	3.79%	-49.20%	Upgrade
EBITDA	26.42	-20.25	-57.73	-18.31	-28.27	Upgrade
EBITDA Margin	14.74%	-17.48%	-49.88%	-13.20%	-26.02%	Upgrade
D&A For EBITDA	2.23	1.24	1	1.16	0.71	Upgrade
EBIT	24.19	-21.49	-58.73	-19.48	-28.97	Upgrade
EBIT Margin	13.49%	-18.55%	-50.74%	-14.04%	-26.67%	Upgrade
Effective Tax Rate	4.80%	-	-	-	-	Upgrade
Revenue as Reported	179.28	116.88	120.24	149.24	108.62	Upgrade

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q